pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-151b |
Genomic Coordinates | chr14: 100109419 - 100109514 |
Description | Homo sapiens miR-151b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-151b | ||||||||||||
Sequence | 60| UCGAGGAGCUCACAGUCU |77 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | RAKE | ||||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | KRT80 | ||||||||||||||||||||
Synonyms | KB20 | ||||||||||||||||||||
Description | keratin 80 | ||||||||||||||||||||
Transcript | NM_001081492 | ||||||||||||||||||||
Other Transcripts | NM_182507 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on KRT80 | |||||||||||||||||||||
3'UTR of KRT80 (miRNA target sites are highlighted) |
>KRT80|NM_001081492|3'UTR 1 CTGCCTCCAGATCAGGCCTCTCCAAGGCCCCCTCCCGAAAGAAGAAGGGCAGCAAAGGCCCCGTGATCAAAATCACCGAA 81 ATGTCAGAGAAGTACTTCTCGCAGGAGTCGGAGGTCTCAGAGTAAGGCGGCTGGACCCCAGGAACCCCAGGGCACTCCAC 161 TGCAGCAGGAGGGACTTAAGCTAGACTCAAGAAAGCAGCTTGGAGCCTCTAGGTTGAGAAGAGAGGCAAAACCTGATATT 241 GAACTGAGAGAGGGGTTCAAAACTGACTGTGTTTTGTGGGCTGCCAGGGTGGGAGAGGAGCATCACCAGCTCCTCAGAGC 321 CACTCCGCTCCATATCAGTATCTCACAGTCCCATCCTTCCAACCTTCTGGCCAGAGGTTTTCCTGATGGGTGAGTCGGAA 401 TTAGGGGTCAGTTTTGTCTCCACCTCCTCGCTCCTCTGAGGCTCCTCCTCCAGCATCAGGCTCTGCCAAGGCCCCTCTGA 481 CTCTTGCCCAATCCTTGACCTTGACTCCTATCTCAAGCCTTGCCTTGTCTCTGCCTCGGAACTGGGACTGGGACTGGCTC 561 ATCCACCTATGTGCGGGAGCCGAGGAGGACGGCGTGGGCCCTGTCCTGTATCTGGAATTCCTGGGAAGGCTGGCTGCTGA 641 AGACCCTCTTGGCTTTCCCGTGCTCTTTGGGCTCCCCAGAGACCTGACAGTATTAGGGAGTGAAGGGAGGAGGGGCCCTG 721 GCTATTTGGGACCTAAGCCTAGGCCCCAGAGATCAGCCCGAACACCCGCATCCCTTCCTCCTCCCATGGGTCCCTCCCAG 801 TAGGCAGTAGTCAGAACTGGATGGGCTGCCCCCAGCCAGCTCCCAGCAGCTTCTCCGGAAGCTGCTCTTGCCATAATCAA 881 CTCCCTGGGAGTGGAAGCCAGATGGCAGCTTGAGATTGGGCAGGAGCATTCGATCTTCCTTTCACCTCCCTGCCATGCTG 961 GGGTCCTACCCAGCCTGGATCTGAGCTCTGTGCCCCCAGCCGGGTTGTTCCCAGCCTGAGCACCGGGCTTTGGTGCACCA 1041 GGCCTTGGAGACCCCTGGTCCCACCCCTGCCGTGAAGCCCCAGGCCCACTTCCCAAGAATCTCACTTCTCAGGGCCTCTG 1121 TTCTCCTCTCCACTGGGCCAAATAGCCTGGCCCTCCCCTCCTTGGCATTCATGGGGGAGCCCAGGAACCCCCCACACCTA 1201 TGGGGTTAGAGCTCCTCCTTTCTTCTCACTCCTTCCCCTTCCTCCCTCCATGCCCACTCCCCCTGCCTCCAGCAGGCCAG 1281 GAAGAAGGCACAGTCCAGGCAAGTCTGGGAGCTTCCAAGCCCTTGAGGTCCAGCTGTGGGGCCCAAATGACAGCCTTACA 1361 AGGGTTCTACCAGAGAGGAAAATTCCACATCCCACCAGAAGACAGGGGTGTTGGCAGGCATACTCCTATCTCCTCCTCTT 1441 GGCTCTCAATGCTGAGGCTTGCAGAGGCATCCCAGCGGCACCAGCCTCCCACTGCACAGCTTCCTTCCCTCCTTCACTCT 1521 CCTCTCCCCTCCCTGCCCCTTGCCTCACCTCCTCTTCTAGACTGCATTAGATTCATTCATCTCATTTGCCAGGACATGTT 1601 GGCCAGAGGTCTGGGCCCATCCCAGGCCTCAAGGCCCTCCAGGCCTGTGGGGAGCACTGGAGGGTTACTGACTCTCTGGC 1681 CATGGGAACTCAGAGATTCTCATCCCCAAAGTCCCAAAAGAGGGTGCTGATTGGTGCTTTTCCTCAGGCTCTTCATTGGT 1761 TTCCAAGGGAGCAAATCCTCAGTGGGGATACAAGACATATAAAGTATATATTATTTTTTCATAACTTATGTGGCTTTTAA 1841 CTTATTGCTTCCCTTCCTGTTTCTGCATGATCAGTCTGTATGTACTATCTGGAAAGATAACACATACTCCAGCCACCTCA 1921 CCTGATTGGCTATCTTGGGGCCATGTCCCCTTCTTGCTGCCACAGGATGAATAAAGTGTTGAGATTTGTCTATGGAGAAA 2001 GCTGTGTGTCTGTTTTTATCTCCCCTCTCAGGACCAGTCAGCCACTGGTCAATCAGGCTGATCATGGAACATTAGGAATT 2081 CTCCAATTAAGGGAGAAAAAGTCCAGGGACTTAGTTATATCTTCAGACCAGTGCAGCTGGTACACACAAAGTTCTCCTGT 2161 CTCACCATCTGATATGGTTTGGATGCTCGTCCCCTCCAAATCTCATGTTGAAATGTAATTCCCAGTGTTGGAAGTGGAGC 2241 CTGGTGGGAAGTATTTGGATCATGAGAGAGGATCCTTCATGAATGGCTCAGCACCATCTCCTTGGTGATGAGTGAGTTCT 2321 CACTCAATTCACATAGATATGGTTGTTTAAAAGAGTCTGAGACCTCTCCCCTCTTTCTCGCCATGTGATATGCCTGCTCC 2401 CCCTTCACCTTCCGCCTTTACTGTAAGCTTCCTGAGGCCCTCACCAGAAGCTGAGCAAATGTTGGTGCCATGCCAGTACA 2481 GCCTGCAGAATTGTGAGCCAAAATAAATGTCTTTTCTTTATAAATTA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Hela | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1048187. RNA binding protein: AGO2. Condition:Hela_AGO2_CLIP_control
... - Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al., 2013, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al. - Cell, 2013
The induction of pluripotency or trans-differentiation of one cell type to another can be accomplished with cell-lineage-specific transcription factors. Here, we report that repression of a single RNA binding polypyrimidine-tract-binding (PTB) protein, which occurs during normal brain development via the action of miR-124, is sufficient to induce trans-differentiation of fibroblasts into functional neurons. Besides its traditional role in regulated splicing, we show that PTB has a previously undocumented function in the regulation of microRNA functions, suppressing or enhancing microRNA targeting by competitive binding on target mRNA or altering local RNA secondary structure. A key event during neuronal induction is the relief of PTB-mediated blockage of microRNA action on multiple components of the REST complex, thereby derepressing a large array of neuronal genes, including miR-124 and multiple neuronal-specific transcription factors, in nonneuronal cells. This converts a negative feedback loop to a positive one to elicit cellular reprogramming to the neuronal lineage.
LinkOut: [PMID: 23313552]
|
CLIP-seq Support 1 for dataset GSM1048187 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | Hela / Hela_AGO2_CLIP_control |
Location of target site | ENST00000313234.5 | 3UTR | UAGGGGUCAGUUUUGUCUCCACCUCCUCGCUCCUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23313552 / GSE42701 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
25 hsa-miR-151b Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT249674 | SLC39A9 | solute carrier family 39 member 9 | 2 | 4 | ||||||||
MIRT366296 | GDI1 | GDP dissociation inhibitor 1 | 2 | 4 | ||||||||
MIRT451313 | LGALS3BP | galectin 3 binding protein | 2 | 2 | ||||||||
MIRT467467 | SMYD1 | SET and MYND domain containing 1 | 2 | 4 | ||||||||
MIRT477248 | ERGIC2 | ERGIC and golgi 2 | 2 | 2 | ||||||||
MIRT489948 | RFX2 | regulatory factor X2 | 2 | 2 | ||||||||
MIRT490364 | SLC6A1 | solute carrier family 6 member 1 | 2 | 4 | ||||||||
MIRT494531 | BCL7A | BCL tumor suppressor 7A | 2 | 2 | ||||||||
MIRT500190 | BARX1 | BARX homeobox 1 | 2 | 4 | ||||||||
MIRT511912 | FKBP1A | FK506 binding protein 1A | 2 | 2 | ||||||||
MIRT524875 | ARHGDIA | Rho GDP dissociation inhibitor alpha | 2 | 6 | ||||||||
MIRT555338 | PPP1R3B | protein phosphatase 1 regulatory subunit 3B | 2 | 4 | ||||||||
MIRT557122 | HOXA3 | homeobox A3 | 2 | 2 | ||||||||
MIRT559034 | C20orf24 | chromosome 20 open reading frame 24 | 2 | 4 | ||||||||
MIRT559824 | SLPI | secretory leukocyte peptidase inhibitor | 2 | 2 | ||||||||
MIRT568547 | AKT2 | AKT serine/threonine kinase 2 | 2 | 2 | ||||||||
MIRT568714 | TMEM30B | transmembrane protein 30B | 2 | 2 | ||||||||
MIRT569827 | CRMP1 | collapsin response mediator protein 1 | 2 | 2 | ||||||||
MIRT687618 | LYRM4 | LYR motif containing 4 | 2 | 2 | ||||||||
MIRT689949 | MANSC1 | MANSC domain containing 1 | 2 | 2 | ||||||||
MIRT690433 | FAM71F2 | family with sequence similarity 71 member F2 | 2 | 2 | ||||||||
MIRT694845 | KRT80 | keratin 80 | 2 | 2 | ||||||||
MIRT697594 | YME1L1 | YME1 like 1 ATPase | 2 | 2 | ||||||||
MIRT697848 | UBE2Z | ubiquitin conjugating enzyme E2 Z | 2 | 2 | ||||||||
MIRT719553 | CBLB | Cbl proto-oncogene B | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|